STOCK TITAN

Amprius Technologies, Inc. SEC Filings

AMPX NYSE

Welcome to our dedicated page for Amprius Technologies SEC filings (Ticker: AMPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Amprius Technologies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Amprius Technologies's regulatory disclosures and financial reporting.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Amprius Technologies CEO Thomas M. Stepien reported an open-market sale of 60,702 shares of common stock at an average price of $14.7884 per share. According to the disclosure, this non-discretionary sale was mandated by the company to cover tax withholding obligations tied to the vesting of restricted stock units.

After the sale, Stepien holds 699,298 shares directly, which the filing states includes 625,000 restricted stock units that may convert into common shares as they vest under their applicable schedules and conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Amprius Technologies filed an amendment to update details on its recently completed warrant-for-share exchange. On May 18 and May 19, 2026, the company issued an aggregate of 2,726,631 shares of common stock to institutional holders in exchange for 7,128,458 public warrants, which were surrendered and cancelled.

The shares were issued as unregistered securities in private transactions relying on Section 4(a)(2) of the Securities Act, meaning they cannot be freely resold in the United States without an effective registration statement or a valid exemption.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.46%
Tags
current report
-
Rhea-AI Summary

Amprius Technologies, Inc. entered into Warrant Exchange Agreements with certain institutional holders of its public warrants. These holders agreed to exchange an aggregate of 7,128,458 public warrants, each with a strike price of $11.50 per share, for shares of common stock.

The number of shares each holder receives will be based on a formula using the four-day average volume-weighted average price of the common stock, adjusted by adding $0.35 and subtracting the exercise price, then dividing by the same average price. Closing of the exchanges is expected on May 18, 2026, subject to customary conditions, and the unregistered issuance of these shares relies on the Section 4(a)(2) exemption under the Securities Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.4%
Tags
current report
Rhea-AI Summary

Stepien Thomas M reported acquisition or exercise transactions in this Form 4 filing.

Amprius Technologies, Inc. reported that Chief Executive Officer Thomas M. Stepien received a grant of 200,000 shares of common stock at a price of $0.00 per share as a compensation-related award. Following this grant, he directly holds 760,000 shares of Amprius common stock.

The amended filing clarifies the vesting schedule for the underlying restricted stock units. 2/16 of the shares will vest on May 20, 2026, and 1/16 will vest quarterly on each August 20, November 20, February 20, and May 20, subject to his continued service, until the award is fully vested on November 20, 2029.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.4%
Tags
insider
-
Rhea-AI Summary

Amprius Technologies reported strong Q1 2026 revenue growth but continued losses and heavy cash use. Revenue rose to $28.5 million from $11.3 million, driven by higher SiCore battery sales and new customers, lifting gross margin to 20% from a negative margin a year earlier. Operating expenses increased as the company expanded R&D and administrative functions, and Amprius posted a net loss of $5.0 million, improved from a $9.4 million loss.

Cash and cash equivalents were $62.4 million as of March 31, 2026, but operating cash outflow was $37.3 million, largely due to a $20.0 million payment to terminate the Brighton, Colorado plant lease. The company now relies on a global contract manufacturing network and is expanding its Fremont pilot line, supported by an $18.1 million U.S. Defense Innovation Unit contract and related government grant income. Revenue remains concentrated, including sizable shipments into EMEA and Ukraine, and the business continues to face global macro, defense and trade risks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.4%
Tags
quarterly report
-
Rhea-AI Summary

Amprius Technologies, Inc. director Sun Kang received an equity compensation grant of 6,250 shares of common stock in the form of restricted stock units at a price of $0.00 per share. This is a grant/award acquisition rather than an open-market purchase.

Each restricted stock unit represents the right to receive one share of common stock, subject to vesting. One-eighth of the award will vest on May 20, 2026, with additional vesting each quarter on August 20, November 20, February 20 and May 20 until the grant is fully vested on February 20, 2028, assuming continued service. After this grant, Kang directly holds 1,348,650 shares, including 1,165,635 restricted stock units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.4%
Tags
insider
Rhea-AI Summary

Amprius Technologies reported strong growth for Q1 2026, with revenue of $28.5 million, up 2.5x from $11.3 million a year earlier, and record quarterly sales. GAAP gross margin reached 20%, turning from a negative margin of (21%) in Q1 2025 as gross profit rose to $5.7 million.

The company still posted a net loss of $5.0 million, but this improved 46% from $9.4 million, with net loss per share narrowing to $0.04 from $0.08. Non-GAAP Adjusted EBITDA was ($1.8) million, a $3.4 million year-over-year improvement.

Management raised its 2026 revenue outlook to at least $130 million and reiterated targets for full-year net loss below $8.0 million, net loss per share under $0.06, Adjusted EBITDA of at least $4.0 million, and capital expenditure under $10.0 million. Business highlights included a $21.0 million light electric vehicle purchase order and expansion of U.S. defense and contract manufacturing relationships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.4%
Tags
current report

FAQ

How many Amprius Technologies (AMPX) SEC filings are available on StockTitan?

StockTitan tracks 90 SEC filings for Amprius Technologies (AMPX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Amprius Technologies (AMPX)?

The most recent SEC filing for Amprius Technologies (AMPX) was filed on May 26, 2026.